These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Antigenicity testing of inactivated oral enteric bacterial vaccines for human use. Joó I Dev Biol Stand; 1976; 33():75-9. PubMed ID: 782974 [TBL] [Abstract][Full Text] [Related]
8. Development of antisera to detect virulent Yersinia enterocolitica, Shigella and Escherichia coli enteroinvasive. Giannini MJ; de Medeiros BM; Bauab TM; Carlos IZ; de Toledo MR; Trabulsi LR; Falcão DP Contrib Microbiol Immunol; 1991; 12():164-70. PubMed ID: 1935085 [No Abstract] [Full Text] [Related]
9. Efficacy of a polyvalent protein-polysaccharide dysentery oral vaccine. Zhang HM; Li YP; Song LH; Yu XL; Liu NH; Kong XE; Li L; Zhai YL Chin Med J (Engl); 1987 May; 100(5):425-8. PubMed ID: 3115716 [No Abstract] [Full Text] [Related]
11. The cellular and humoral immune response after administration to the guinea pig of Shigella flexneri 2a T32--Istrati vaccinal strain by different routes. Meitert T; Radu I; Ciudin L; Pencu E; Tonciu M Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):267-76. PubMed ID: 395927 [No Abstract] [Full Text] [Related]
12. An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccines. Levine MM; Rice PA; Gangarosa EJ; Morris GK; Snyder MJ; Formal SB; Wells JG; Gemski P; Hammond J Am J Epidemiol; 1974 Jan; 99(1):30-6. PubMed ID: 4590191 [No Abstract] [Full Text] [Related]
15. Successful field trials with oral killed Shigella sonnei vaccine. Grahneis H Acta Microbiol Acad Sci Hung; 1974; 21(1-2):75-80. PubMed ID: 4613141 [No Abstract] [Full Text] [Related]
16. Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains. Mel D; Gangarosa EJ; Radovanovic ML; Arsic BL; Litvinjenko S Bull World Health Organ; 1971; 45(4):457-64. PubMed ID: 4948417 [TBL] [Abstract][Full Text] [Related]
17. Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli. Noriega FR; Losonsky G; Wang JY; Formal SB; Levine MM Infect Immun; 1996 Jan; 64(1):23-7. PubMed ID: 8557344 [TBL] [Abstract][Full Text] [Related]
18. [Live vaccines for the prevention of intestinal infections]. Sergeev VV; Kreynin LS; Lichoded VG; Elkina CU; Zukova LF; Kaverina KG Arch Exp Veterinarmed; 1980; 34(1):87-9. PubMed ID: 6998403 [TBL] [Abstract][Full Text] [Related]
19. [Vaccination against the enterobacteria responsible for enteric infections]. Sansonetti PJ Ann Gastroenterol Hepatol (Paris); 1994; 30(2):60-3. PubMed ID: 8210205 [TBL] [Abstract][Full Text] [Related]
20. Immunity of the guinea pig's eye after vaccination with Shigella sonnei phase I antigen. Kerekes L Acta Microbiol Acad Sci Hung; 1976; 23(4):353-8. PubMed ID: 799899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]